Rwanda: Clear the Air, Health Ministry

editorial

Kigali — It has been reported that Apotex Inc., Canada's largest pharmaceutical company will soon ship to Rwanda a new HIV/Aids drug. Apo-TriAvir combines Zidovudine, Lamivudine and Nevirapine, three drugs otherwise administered separately to patients.

Apotex plans to dispatch pills to the tune of 15.6 million in the first consignment sometime in October this year. The scheme will be made possible courtesy of Canadian Access to Medicine Regime (CAMR).

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.